C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/1999
12/29/1999	CA2334322A1 Syntheses of a variety of lamellarin compounds and analogues
12/29/1999	CA2325388A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999	CA2324475A1 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
12/29/1999	CA2324474A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999	CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/28/1999	US6008356 Pharmaceutically available protoberberine salts derivatives, and protoberberine salts derivatives, and protoberberine derivatives and salts thereof
12/28/1999	US6008230 Treating bone diseases caused by abnormal bone metabolism in human being or animals as the inhibitors of bone resorption or the inhibitors of bone metastasis
12/28/1999	US6008229 Treating allergy, inflammation, autoimmune disease, shock, pain
12/28/1999	US6008215 Benzonaphthyridines as bronchial therapeutics
12/23/1999	WO1999065910A1 Fused azepinone cyclin dependent kinase inhibitors
12/23/1999	WO1999065906A1 Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
12/23/1999	WO1999065904A1 Triazolo-pyridine derivatives as ligands for gaba receptors
12/23/1999	WO1999065903A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
12/23/1999	WO1999065902A1 METHOD FOR PRODUCING 2,4-DIMETHYLCARBOLINE AND 2,4-DIMETHYLPYRIMIDO[1,2-a]INDOLE
12/23/1999	WO1999065896A1 Preparation of heteroaryl compounds
12/23/1999	WO1999065494A1 Inhibitors of prenyl-protein transferase
12/23/1999	WO1999065488A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
12/23/1999	WO1996002535A8 Process for synthesis of substituted sulphoxides
12/23/1999	CA2335112A1 Therapeutic combinations for musculoskeletal frailty
12/23/1999	CA2334900A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
12/23/1999	CA2334836A1 Triazolo-pyridine derivatives as ligands for gaba receptors
12/23/1999	CA2334677A1 Preparation of heteroaryl compounds
12/22/1999	EP0964864A2 Pyrido 2,3-d] pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
12/22/1999	EP0758312B1 Substituted fused and bridged bicyclic compounds as therapeutic agents
12/22/1999	EP0635018B1 4-(1H-2-METHYLIMIDAZO[4,5-c]PYRIDINYLMETHYL)PHENYLSULPHONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF
12/22/1999	CN1239478A 1-aryl-1,8-naphthylidin-4-one derivative as type IV phosphodiesterase inhibitor
12/22/1999	CN1239094A Process for preparing quinolone- and naphthyridonecarboxylic acids and esters thereof
12/21/1999	US6005110 Process for the production of endotropine
12/21/1999	US6005108 N-([1,2,4]triazoloazinyl)benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides
12/21/1999	US6005106 Naphthalene derivatives, process for the preparation therof, and intermediates thereof
12/21/1999	US6004976 Administering imidazo(4,5-c)pyridin-2,4-dione derivatives as anticoagulants
12/21/1999	US6004974 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
12/21/1999	US6004966 Use of xanthine oxidase inhibitors as anti-ischaemic agents
12/21/1999	CA2060624C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
12/21/1999	CA2035653C Neuroprotective 3-piperidino-4-hydrosychroman derivatives
12/16/1999	WO1999064422A1 Pyrido[2,3-b]indolizine derivatives and aza analogues thereof; crf1 specific ligands
12/16/1999	WO1999064421A1 Acetylcholine enhancers
12/16/1999	WO1999064420A1 β-CARBOLINE COMPOUNDS
12/16/1999	WO1999064419A1 Pyrrole derivatives, preparation method and pharmaceutical compositions containing same
12/16/1999	WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999	WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999	WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	WO1999064051A1 Novel antibacterial compounds
12/16/1999	WO1999064049A1 Novel antibacterial agents
12/16/1999	WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999	WO1999064047A1 Novel antiviral compounds
12/16/1999	WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999	WO1999064039A1 Bradykinin antagonists
12/16/1999	WO1999064038A1 Novel analgesic agents
12/16/1999	WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999	WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064002A1 Spiropiperidine derivatives as melanocortin receptor agonists
12/16/1999	WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	WO1999063999A1 H1-histamine receptor antagonists
12/16/1999	WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	WO1999063994A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
12/16/1999	WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999	WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999	WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999	WO1999063939A2 Multibinding inhibitors of cyclooxygenase-2
12/16/1999	WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999	WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999	WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	WO1999055693A3 N-heteroaryl-substituted pyridine derivatives and their use as herbicides
12/16/1999	DE19826050A1 Verfahren zur Herstellung von Chinolon- und Naphthyridoncarbonsäuren und deren Ester Process for the preparation of quinolone- and naphthyridonecarboxylic acids and esters thereof
12/16/1999	CA2335339A1 .beta.-carboline compounds
12/16/1999	CA2334945A1 Imidazolyl derivatives
12/16/1999	CA2334671A1 Pyrido¬2,3-b\|indolizine derivatives and aza analogues thereof; crf1 specific ligands
12/16/1999	CA2334551A1 Spiropiperidine derivatives as melanocortin receptor agonists
12/16/1999	CA2331794A1 Acetylcholine enhancers
12/16/1999	CA2321274A1 Novel antiviral compounds
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999	CA2321162A1 Novel antibacterial compounds
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2320290A1 Multibinding inhibitors of cyclooxygenase-2
12/16/1999	CA2320241A1 Multivalent macrolide antibiotics
12/16/1999	CA2319761A1 Multibinding inhibitors of hmg-coa reductase
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319730A1 Bradykinin antagonists
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors

1 ... 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 ... 646